600201 生物股份
2025/03 - 三个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)1.4412.0415.4344.0737.456
总资产报酬率 ROA (%)1.1361.5984.2773.2435.935
投入资产回报率 ROIC (%)1.3341.9385.3083.9897.321

边际利润分析
销售毛利率 (%)54.52653.85558.98555.17261.880
营业利润率 (%)27.3359.93019.72216.68823.344
息税前利润/营业总收入 (%)23.6955.98816.24813.05420.989
净利润/营业总收入 (%)21.9598.29617.33813.09121.900

收益指标分析
经营活动净收益/利润总额(%)70.913107.975107.875126.885108.232
价值变动净收益/利润总额(%)14.477-7.595-2.463-3.9960.772
营业外收支净额/利润总额(%)-0.1420.1970.197-3.874-0.335

偿债能力分析
流动比率 (X)3.1123.0223.5884.0694.006
速动比率 (X)2.6892.6163.2053.5633.545
资产负债率 (%)19.28219.94617.71716.27215.804
带息债务/全部投入资本 (%)-3.553-3.307-4.500-5.055-4.757
股东权益/带息债务 (%)-2,610.449-2,795.606-2,169.748-1,933.175-2,063.599
股东权益/负债合计 (%)410.579393.861440.760487.852505.154
利息保障倍数 (X)-6.581-1.512-4.625-4.336-9.217

营运能力分析
应收账款周转天数 (天)166.421213.742182.538175.724135.251
存货周转天数 (天)163.277191.674180.055171.026177.657